Zydus Lifesciences informs about press release

27 Sep 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated September 27, 2024, titled ‘Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for chronic kidney disease induced Osteoporosis’.

The above information is a part of company’s filings submitted to BSE. 

Zydus Lifesciences Share Price

912.90 -1.75 (-0.19%)
01-Jan-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.95
Dr. Reddys Lab 1249.95
Cipla 1499.90
Zydus Lifesciences 912.90
Lupin 2099.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×